UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
------------------------
Date of Report (Date of earliest event reported): November 12, 2002
IMMUNOGEN, INC.
(Exact name of registrant as specified in its Charter)
Massachusetts 0-17999 04-2726691
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
128 Sidney Street, Cambridge, Massachusetts 02139
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (617) 995-2500
ITEM 9. REGULATION FD DISCLOSURE
On November 12, 2002, the Registrant filed its Quarterly Report on Form 10-Q
for the fiscal quarter ended September 30, 2002 with the Securities and
Exchange Commission. In connection with the filing of the Form 10-Q, attached
hereto as exhibits are certifications of the Registrant's Chief Executive
Officer and Chief Financial Officer, as required by 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
These certifications are being furnished herewith solely to accompany the Form
10-Q, pursuant to 18 U.S.C. Section 1350, are not being filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended and are not to be
incorporated by reference into any of the Registrant's filings with the
Securities and Exchange Commission, whether filed prior to or after the
furnishing of these certifications, regardless of any general or specific
incorporation language in any such filing.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits.
99.1 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
United States Code)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereto duly authorized.
ImmunoGen, Inc.
(Registrant)
Date: November 12, 2002 /s/ Gregg D. Beloff
---------------------------
Gregg D. Beloff
Chief Financial Officer
and Vice President, Finance